The deep-seated and multi-faceted cancer, driven by genetic mutations, has remained a major hurdle for both detection as well as therapeutic management. Single-cell RNA sequencing (scRNA-seq) has emerged as a powerful approach for understanding the heterogeneity found in cancer and identifying potential therapeutic targets. In this study, we elucidate its function in the context of laryngeal squamous cell carcinoma (LSCC). In order to explore novel molecular-targeted biomarkers and establish precise monitoring strategies for the diagnosis, and treatment of LSCC based on acute transcriptome screening results by using scRNA-seq data (GSE252490). After data processing, quality control and standardization took place followed by the detection of highly variable genes optimization using principal component analysis. Further cell clustering revealed 12 discrete clusters with unique molecular features. We finally detected 6434 differentially expressed genes (DEGs) by comparing the marker gene with the human homolog. Gene ontology enrichment analysis indicates the biological processes associated with LSCC progression. Protein-protein interaction (PPI) network construction revealed twenty central genes associated with multiple key pathways involved in building up cancer. Pathway enrichment by the KEGG pathway was used to underline the involvement of these centric genes in various cancer-related pathways. Moreover, the evaluation of mRNA expression and clinical prognosis further confirmed their significance in LSCC. Of these genes, CCL3, EPCAM, and IL8 with increased expression levels are linked to the survival rate in LSCC. The present analysis provides insight into the molecular landscape of LSCC, thereby identifying potential candidates for diagnosis and targeted therapy.